Adipocyte‐Derived Exosomal MTTP Suppresses Ferroptosis and Promotes Chemoresistance in Colorectal Cancer

Obesity is closely related to a poor prognosis in patients with advanced colorectal cancer (CRC), but the mechanisms remain unclear. Ferroptosis is a form of nonapoptotic cell death characterized by lipid reactive oxygen species (ROS) accumulation and iron dependency and is associated with the chemoresistance of tumors. Here, it is shown that adipose‐derived exosomes reduce ferroptosis susceptibility in CRC, thus promoting chemoresistance to oxaliplatin. It is found that microsomal triglyceride transfer protein (MTTP) expression is increased in the plasma exosomes of CRC patients with a high body fat ratio, serving as an inhibitor of ferroptosis and reducing sensitivity to chemotherapy. Mechanistically, the MTTP/proline‐rich acidic protein 1 (PRAP1) complex inhibited zinc finger E‐box binding homeobox 1 expression and upregulated glutathione peroxidase 4 and xCT, leading to a decreased polyunsaturated fatty acids ratio and lipid ROS levels. Moreover, experiments are carried out in organoids, and a tumor implantation model is established in obese mice, demonstrating that the inhibition of MTTP increases the sensitivity to chemotherapy. The results reveal a novel intracellular signaling pathway mediated by adipose‐derived exosomes and suggest that treatments targeting secreted MTTP might reverse oxaliplatin resistance in CRC.

[1]  B. Stockwell,et al.  Ferroptosis: mechanisms, biology and role in disease , 2021, Nature Reviews Molecular Cell Biology.

[2]  M. Kamal,et al.  Exosomes: Critical mediators of tumour microenvironment reprogramming. , 2020, Current medicinal chemistry.

[3]  B. Zacharia,et al.  Neutrophil-induced ferroptosis promotes tumor necrosis in glioblastoma progression , 2020, Nature Communications.

[4]  L. Zhuang,et al.  Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy , 2020, Protein & Cell.

[5]  J. Roh,et al.  Epigenetic reprogramming of epithelial-mesenchymal transition promotes ferroptosis of head and neck cancer , 2020, Redox biology.

[6]  E. Ortlund,et al.  Proline-Rich Acidic Protein 1 (PRAP1) Protects the Gastrointestinal Epithelium From Irradiation-Induced Apoptosis , 2020, Cellular and molecular gastroenterology and hepatology.

[7]  Xiaoqun Duan,et al.  Targeting SLC7A11 specifically suppresses the progression of colorectal cancer stem cells via inducing ferroptosis. , 2020, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[8]  Stephen A. Sastra,et al.  Cysteine depletion induces pancreatic tumor ferroptosis in mice , 2020, Science.

[9]  M. Jolly,et al.  ZEB1: A Critical Regulator of Cell Plasticity, DNA Damage Response, and Therapy Resistance , 2020, Frontiers in Molecular Biosciences.

[10]  De Chen,et al.  Small Protein Hidden in lncRNA LOC90024 Promotes “Cancerous” RNA Splicing and Tumorigenesis , 2020, Advanced science.

[11]  Gang Wu,et al.  Irradiated tumor cell–derived microparticles mediate tumor eradication via cell killing and immune reprogramming , 2020, Science Advances.

[12]  R. Liu,et al.  CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer , 2020, Molecular Cancer.

[13]  G. Fournet,et al.  Dual disruption of aldehyde dehydrogenases 1 and 3 promotes functional changes in the glutathione redox system and enhances chemosensitivity in nonsmall cell lung cancer , 2020, Oncogene.

[14]  Xiaochen Dong,et al.  Recent Progress in Ferroptosis Inducers for Cancer Therapy , 2019, Advanced materials.

[15]  Ahmedin Jemal,et al.  Cancer treatment and survivorship statistics, 2019 , 2019, CA: a cancer journal for clinicians.

[16]  D. Dean,et al.  ZEB1 promotes inflammation and progression towards inflammation-driven carcinoma through repression of the DNA repair glycosylase MPG in epithelial cells , 2019, Gut.

[17]  T. Vanden Berghe,et al.  Targeting Ferroptosis to Iron Out Cancer. , 2019, Cancer cell.

[18]  W. Gu,et al.  ALOX12 is required for p53-mediated tumor suppression through a distinct ferroptosis pathway , 2019, Nature Cell Biology.

[19]  M. Conrad,et al.  Role of GPX4 in ferroptosis and its pharmacological implication. , 2019, Free radical biology & medicine.

[20]  F. Zhang,et al.  Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia/reperfusion , 2019, Cell Death & Differentiation.

[21]  L. Zhuang,et al.  BAP1 suppresses tumor development by inducing ferroptosis upon SLC7A11 repression , 2018, Molecular & cellular oncology.

[22]  T. Nell,et al.  Chemoresistance: Intricate Interplay Between Breast Tumor Cells and Adipocytes in the Tumor Microenvironment , 2018, Front. Endocrinol..

[23]  Ting Duan,et al.  RSL3 Drives Ferroptosis Through GPX4 Inactivation and ROS Production in Colorectal Cancer , 2018, Front. Pharmacol..

[24]  S. Vesely,et al.  Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade , 2018, Nature Medicine.

[25]  L. Zhuang,et al.  Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer , 2018, Cancer communications.

[26]  Zhenyu Li,et al.  Ferroptosis: A Novel Anti-tumor Action for Cisplatin , 2017, Cancer research and treatment : official journal of Korean Cancer Association.

[27]  M. Selak,et al.  Resistance Is Futile: Targeting Mitochondrial Energetics and Metabolism to Overcome Drug Resistance in Cancer Treatment. , 2017, Cell metabolism.

[28]  B. Stockwell,et al.  Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease , 2017, Cell.

[29]  Jill P. Mesirov,et al.  Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway , 2017, Nature.

[30]  Stuart L. Schreiber,et al.  Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition , 2017, Nature.

[31]  A. Walch,et al.  ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. , 2017, Nature chemical biology.

[32]  Simon C Watkins,et al.  Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. , 2017, Nature chemical biology.

[33]  D. Tang,et al.  Identification of ACSL4 as a biomarker and contributor of ferroptosis. , 2016, Biochemical and biophysical research communications.

[34]  E. Giovannucci,et al.  Preventable Incidence and Mortality of Carcinoma Associated With Lifestyle Factors Among White Adults in the United States. , 2016, JAMA oncology.

[35]  J. Meyerhardt,et al.  Analysis of Body Mass Index and Mortality in Patients With Colorectal Cancer Using Causal Diagrams. , 2016, JAMA oncology.

[36]  Q. Pan,et al.  Ferroptosis is an autophagic cell death process , 2016, Cell Research.

[37]  D. Tang,et al.  Metallothionein‐1G facilitates sorafenib resistance through inhibition of ferroptosis , 2016, Hepatology.

[38]  Dorothy D. Sears,et al.  Circulating adipocyte-derived extracellular vesicles are novel markers of metabolic stress , 2016, Journal of Molecular Medicine.

[39]  Toshio Uraoka,et al.  A Colorectal Tumor Organoid Library Demonstrates Progressive Loss of Niche Factor Requirements during Tumorigenesis. , 2016, Cell stem cell.

[40]  W. Jia,et al.  Redox Regulation of Stem-like Cells Though the CD44v-xCT Axis in Colorectal Cancer: Mechanisms and Therapeutic Implications , 2016, Theranostics.

[41]  D. Tang,et al.  Activation of the p62‐Keap1‐NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells , 2016, Hepatology.

[42]  Peng Huang,et al.  Xc- inhibitor sulfasalazine sensitizes colorectal cancer to cisplatin by a GSH-dependent mechanism. , 2015, Cancer letters.

[43]  M. Zou,et al.  Mitochondrial ROS and cancer drug resistance: Implications for therapy. , 2015, Pharmacological research.

[44]  W. Gu,et al.  Ferroptosis as a p53-mediated activity during tumour suppression , 2015, Nature.

[45]  Li Ma,et al.  ZEB1: At the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance , 2015, Cell cycle.

[46]  A. Walch,et al.  Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice , 2014, Nature Cell Biology.

[47]  Matthew E. Welsch,et al.  Regulation of Ferroptotic Cancer Cell Death by GPX4 , 2014, Cell.

[48]  J. Slingerland,et al.  Cytokines, obesity, and cancer: new insights on mechanisms linking obesity to cancer risk and progression. , 2013, Annual review of medicine.

[49]  Yongzhi Yang,et al.  Obesity and Risk of Colorectal Cancer: A Systematic Review of Prospective Studies , 2013, PloS one.

[50]  M. R. Lamprecht,et al.  Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death , 2012, Cell.

[51]  N. Plesnila,et al.  Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death. , 2008, Cell metabolism.

[52]  J. Loscalzo.  Membrane redox state and apoptosis: death by peroxide. , 2008, Cell metabolism.

[53]  Z. Siddik,et al.  Cisplatin: mode of cytotoxic action and molecular basis of resistance , 2003, Oncogene.

[54]  S A Jebb,et al.  Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. , 2000, The American journal of clinical nutrition.

[55]  G. Hortobagyi,et al.  Obesity as an Adverse Prognostic Factor for Patients Receiving Adjuvant Chemotherapy for Breast Cancer , 1994, Annals of Internal Medicine.

[56]  D. B. Zilversmit,et al.  Purification and characterization of microsomal triglyceride and cholesteryl ester transfer protein from bovine liver microsomes. , 1985, Chemistry and physics of lipids.

[57]  P. Subbaiah,et al.  Studies on the phospholipases of rat intestinal mucosa. , 1970, The Biochemical journal.